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We have adopted the clinical concept of gallstone hepatitis indicated by marked serum
transaminase elevation due to an acute inflammatory liver cell necrosis in the early stages of
gallstone impaction in the bile duct as clinical and biochemical criteria for identifying high-risk
patients for acute cholangitis or bile duct stones causing symptoms (symptomatic bile duct
stones, SBDS).
One hundred and fifty-eight (80.2%) of 197 patients with acute gallstone disease and
concomitant elevation of serum transaminase (gallstone hepatitis) underwent emergency
treatment, either surgery (138 patients) or percutaneous transhepatic biliary drainage
(PTBD)/endoscopic sphincterotomy (ES) (20 patients). One hundred and forty-two (89.9%) and
67 (42.4%) were confirmed to have SBDS and acute cholangitis, respectively, in the early stage of
the disease. The majority of the patients who had no bile duct stones identified at surgery had
either biliary pancreatitis or multiple small stones in the gallbladder. They were assumed to have
migrating stones or false negative operative cholangiograms.
In conclusion, gallstone hepatitis indicates that SBDS and acute cholangitis are probable, and
facilitates rapid selection of patients for urgent biliary tract exploration in patients with acute
gallstone disease.




Acute cholangitis is a potentially life-threatening dis-
ease that results from biliary tract obstruction and
subsequent infection. Recognition of the clinical mani-
festations is important in diagnosing and managing
these patients 1. However, reliance on Charcot’s triad
(abdominal pain, fever, and jaundice) is insufficient
and the clinical presentation can be nonspecific2. Ac-
cordingly, a diagnosis of acute cholangitis should be
considered whenever there are signs of biliary tract
obstruction and infection 1. Ideally, bile duct stones
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causing symptoms (symptomatic bile duct stones,
SBDS) should be identified early before acute cholan-
gitis develops. With the rapid and widespread accept-
ance of laparoscopic cholecystectomy as the preferred
primary operation for cholelithiasis, the identification
of SBDS also becomes clinically important. What,
then, is the diagnostic feature that identifies SBDS or
biliary tract obstruction?
We have been involved in a clinicopathological
study to clarify the cause of markedly elevated serum
transaminases in patients with acute gallstone disease,
which might have led to the diagnosis of so-called
hepatitis. We concluded that serum transaminases
might be raised markedly in the very early stage
of biliary obstruction, that this highly elevated serum
transaminases might be a reflection of an acute in-
267268 M. ISOGAI et al.
flammatory liver cell necrosis caused by impacted bile
duct stones (gallstone hepatitis3’4), and that therefore
gallstone hepatitis might be a sign of early biliary tract
obstruction caused by impacted bile duct stones before
serum bilirubin and alkaline phosphatase became elev-
ated4. A case presented below provided further insight
into the pathogenesis of gallstone hepatitis which
could develop into severe acute cholangitis unless bili-
ary decompression occurred 3.
Based upon this background and knowledge, we
have adopted the clinical concept of gallstone hepatitis
as a criterion for identifying patients with acute cholan-
gitis or SBDS. At our hospital, almost all patients with
acute gallstone disease who do not respond to initial
conservative treatment are operated on immediately,
after necessary biliary tract examination, provided the
patients present a reasonable surgical risk. Here, we
present a review of 197 patients who had gallstone
hepatitis and therefore were suspected of having acute
cholangitis or SBDS and were treated at the Depart-
ment of Surgery, Ogaki Municipal Hospital, during the
past 5 years. The main purpose ofthis study is to report
the actual biliary pathology ultimately confirmed at
surgery, especially in the acute stage of the disease, of
patients with gallstone hepatitis.
CASE STUDY
A 69-year-old female was referred to the Department of
Gastroenterology, Ogaki Municipal Hospital, with
epigastric pain and a liver function disorder which had
developed two days before. Serum liver chemistry test
results one day after the onset of symptoms were:
glutamic oxalacetic transaminase (GOT) 2,380 (Kar-
men unit, normal <40); glutamic pyruvic trans-
aminase (GPT) 747 (Karmen unit, normal < 35); and
bilirubin 2.0 (mg/dl, normal < 1.2). She was diagnosed
as having so-called hepatitis and underwent medical
treatment. However, the abdominal pain did not abate
Table 1 Time course of symptoms and liver chemistry
Day* Symptoms GOT 2. GPT
3, T. bil4.
severe epigastric pain ? ?
relief of pain 2380 747 2.0
slight pain 788 863 6.3
slight pain 145 391 1.9
high fever & shock 175 368 14.0
* :Time from onset of symptoms
2* Glutamic oxalacetic transaminase(Karmen unit, normal < 40)
3* Glutamic pyruvic transaminase (Karmen unit, normal < 35)
4*: Total bilirubin (mg/dl, normal < 1.2)
and serum transaminases, especially GPT, remained
high while serum bilirubin fluctuated (Table 1). On the
sixth day after the onset of symptoms she developed
a high fever and shock. An abdominal ultrasonography
(US) scan on that day revealed gallstones in the dilated
bile duct. The diagnosis of gallstone hepatitis followed
by severe acute cholangitis was made, and she under-
went percutaneous transhepatic biliary drainage
(PTBD) (Fig. 1). Following this procedure, a rapid fall
in serum transaminase and bilirubin activity and an
immediate remission of symptoms were observed.
After the resolution of cholangitis, she underwent de-
layed biliary surgery safely.
In this patient, the initial very high levels of serum
transaminases (gallstone hepatitis) led to misdiagnosis
of so-called hepatitis, and this led to a delay in biliary
decompression and to the resultant development of
severe acute cholangitis.
PATIENTS AND METHODS
We have previously classified gallstone hepatitis as
a new clinical entity3’’. The clinical diagnostic criteria
for gallstone hepatitis are: (1) severe abdominal pain;
(2) markedly elevated serum transaminase levels which
might lead to the diagnosis of so-called hepatitis; and
(3) gallstones, usually revealed in the dilated biliary
tract, including the gallbladder, by using US. The
histological features of gallstone hepatitis included: (1)
degeneration and necrosis of liver cells (an accumula-
tion of neutrophils in an area where liver cells had
vanished from liver cell plates); and (2) acute cholangi-
tis (neutrophil infiltration around and into the lumen
of the bile duct in the portal triad). With regard to
serum transaminase levels, the initial levels might de-
pend on the extent of the liver cell necrosis caused by
the impacted bile duct stones. The highly elevated
serum transaminase levels during the onset of symp-
toms fall rapidly after resolution of the bile duct ob-
struction3’. Serum transaminases, however, remain
slightly elevated to various levels above normal when
bile duct stones remain floating, causing bile statis.
Thus, serum transaminase levels might depend on the
extent of ductal obstruction or on the interval between
the onset of the symptoms and the time of carrying out
the biochemical tests. We believe, therefore, that serum
transaminase elevation, no matter how slight, in pa-
tients with acute gallstone disease should lead doctors
to suspect that patients have had gallstone hepatitis in
the course of the disease.
Based upon the features of the course of serum
transaminases in gallstone hepatitis, all patients withGALLSTONE HEPATITIS AND ACUTE CHOLANGITIS 269
Figure Abdominal ultrasonography (US) on the sixth day after onset of symptoms revealed gallstones in the dilated bile duct (A).
Percutaneous transhepatic cholangiography (PTC) showed complete obstruction of the bile duct (B).
gallstones and with serum transaminases at above-
normal levels were diagnosed as having gallstone hepa-
titis. As a result, 197 patients were diagnosed as having
gallstone hepatitis from January 1987 to December
1991. They were treated under suspicion of having
acute cholangitis or SBDS, and entered into this study.
Patients with viral hepatitis or other potential causes of
transaminase elevation such as heart failure or drug or
alcohol abuse were excluded. The patients were ana-
lyzed with respect to clinical presentation, preoperative
examinations, management, biliary tract pathology,
operative procedures, and outcome.
RESULTS
Clinical Presentation
There were 99 males and 98 females; age range was 24
to 98 years, with a mean of 63.2 years.
Jaundice was present in 49 patients (24.9%), fever
exceeding 38C was present in 25 (12.7%), and Char-
cot’s triad was present in 38 (19.3%). Seven patients
(3.6%) showed progression of biliary sepsis (severe
acute cholangitisS): mental confusion and shock in one
patient; shock and disseminated intravascular co-
agulopathy (DIC) in one; shock in 4; and DIC in one.
The serum levels (mean_+ SD) of GOT, GPT, bi-
lirubin amylase, and the white blood cell count were
319 _+ 375,255 + 208,3.4_+ 2.5, and 382+ 733 (Caraway
units, normal < 135), and 10.700+_ 5100 (count/mm3),
respectively. Fifty-five patients (28%) showed serum
GOT levels of over 400 Karmen units, and ten (5.1%)
over 1,000. However, the magnitude of the elevated
serum transaminase did not correlate with the severity
of the symptoms (Fig. 2.) Twenty patients (10.2%) had
concomitant elevation of serum amylase of over 1,000

















"Severe acute cholangitis (7 patients)
"Charcot’s triad (38 patients}
Figure 2 Magnitude of serum transaminase levels and severity of
symptoms. Fifty-five patients (28%) showed serum glutamic
oxalacetic transaminase (GOT) levels of over 400, and ten (5.1%)
showed levels of over 1.000. The magnitude of the elevated serum
transaminase levels, however, did not correlate with the severity of
symptoms.270 M. ISOGAI et al.
Preoperative Examinations
All patients underwent US scan on admission, which
revealed gallstones, usually in the swollen gallblad-
der and/or in the dilated bile duct. Later, some
patients were further studied by drip infusion cholan-
giography, endoscopic retrograde cholangiography
(ERC), percutaneous transhepatic cholangiography
(PTC), or computed tomography, as indicated in order
to detect bile duct stones. The relationship between the
imaging studies and the detection of bile duct stones is
shown in Table 2. Using these studies, 128 patients
(65.0%) were preoperatively diagnosed as having bile
duct stones.
Group III patients and all Group II patients except
one (total of 58 patients) subsequently underwent oper-
ation during the same period of hospitalization, after
an average of 14 days. In one Group II patient who had
previously undergone cholecystectomy, bile duct
stones were removed by ES and delayed surgery was
not required.
In the seven patients with severe acute cholangitis,
emergency surgery was performed in one (Group I),
PTBD in five (Group II), and initial medical manage-
ment in one (Group III).
Biliary Tract Pathology
Management
The management of the 197 patients included: (1)
emergency operation within 48 hours of admission in
138 (70.1%, Group I); (2) successful emergency biliary
drainage, including PTBD (15 cases) or endoscopic
sphincterotomy (ES, 5 cases), in 20 (10.1%, Group II);
and (3) initial medical treatment in 39 (19.8%, Group
III).
The majority of Group I patients showed no objec-
tive improvement in response to conventional support-
ive therapy such as antibiotic, analgesic, or fluid
therapy. ES was unsuccessful in two cases. Deteriora-
tion of their general condition and peritonitis were the
important factors determining emergency surgery. In
some cases, the attending physician performed emerg-
ency surgery for the proven SBDS without initial
conservative management.
Group II patients underwent PTC or ERC prior to
PTBD/ES, which revealed bile duct stones. In nine
patients, pus was identified within the bile duct at
PTBD/ES. Group III patients responded promptly to
initial medical management.
Table 2 Imaging studies and bile duct stones
Imaging Studies Number ofcases Detection ofBDS*
(1) US2. 61 29 (47.5%)
(2) US + DIC3. 31 14 (45.2%)
(3) US + ERC’* 58 49 (84.5%)
(4) US + PTC5. 25 23 (92.0%)
(5) US + Others 22 13 (65.0%)
Total 197 128 (65.0%)
* :Bile duct stones
2*: Ultrasonography
3" Drip infusion cholangiography
4" Endoscopic retrograde cholangiography
5*: Percutaneous transhepatic cholangiogaphy
Biliary tract pathology found at emergency surgery
(Group I, 138 patients) and at delayed surgery (Group
II and Group III, 58 patients) is shown in Table 3.
Acute suppurative cholangitis (ASC) is defined as the
presence of pus within the bile duct 1. At emergency
surgery, SBDS and ASC were confirmed in 122 (88.4%)
and 58 patients (42.0%), respectively. As stated previ-
ously, 20 (100%) and nine (45%) of Group II patients
had SBDS and ASC, respectively, at emergency
PTBD/ES. Accordingly, in the acute stage of the dis-
ease, SBDS and ASC were confirmed in 142 (89.9%)
and 67 patients (42.4%), respectively, out of a total of
158 patients (138 Group I and 20 Group II patients).
Almost all of the patients had acute inflammation of
the gallbladder. In the majority, however, the intensity
of the inflammation was slight.
Laboratory data on admission and features of the
gallbladder stones in the 16 Group I patients and the 18
Group III patients who had no bile duct stones identifi-
ed at emergency and delayed surgery, respectively, are
shown in Table 4. In the 16 Group I patients, four
(25%) had biliary pancreatitis and nine (56.3%) had
multiple small stones less than 4mm in diameter. In the
18 Group II patients, four (22.2%) had biliary pancre-
atitis. Four patients (22.2%) had undergone ES, by
which means the bile duct stones had been removed,
and no bile duct stone was identified at d6layed sur-
gery. The other seven patients (38.9%) had multiple
small stones.
Operative Procedures
Operative procedures performed at emergency surgery
(138 patients) included cholecystectomy alone (chole-
cystectomy) in five (3.6%), cholecystectomy + chole-
dochotomy or choledocholithotomy (ductal explora-
tion) in 99 (71.7%), and cholecystectomy+chole-
dochotomy or choledocholithotomy + transduodenalGALLSTONE HEPATITIS AND ACUTE CHOLANGITIS 271
Table 3 Biliary tract pathology at surgery
Biliary tract pathology Emergency surgery Delayed surgery
(138 cases) (58 cases)
(1) Bile duct stones
(2) Acute suppurative cholangitis*
(3) Acute inflammation of the GB2.
1) non serous or chronic
2) phlegmonous gangrenous
3) perforation or abscess







Table 4 Laboratory data on admission and features ofthe gallbladder stones ofthe 34 patients without bile
duct stones
No. (Age/Sex) Laboratory data* Features ofGB stones
GOT GPT T.bil Amylase Stone Size2. Stone Number
Emerg. Surg.3*:
1. (40/5‘) 692 945 8.7 31705* 2 mm
2. (36/9) 299 260 0.9 25215" 4 mm 3
3. (68/5‘) 229 88 1.1 22135* 20 mm
4. (74/) 55 37 1.1 21145* 5 mm 2
5. (64/5‘) 210 269 2.9 133 2 mm 486
6. (54/5‘) 410 517 8.4 4 mm 200
7. (50/5’) 674 735 2.3 132 2 mm 63
8. (38/5‘) 214 134 1.0 66 2 mm 47
9. (69/5‘) 716 252 2.1 42 3 mm 31
10.(42/5‘) 206 581 2.1 ? 3 mm 28
11. (62/5‘) 282 263 3.3 4 mm 12
12. (73/) 1420 816 3.9 17 3 mm 5
13. (40/5‘) 636 451 2.5 4 mm 2
14. (71/5‘) 332 361 8.3 808 20 mm 2
15. (60/$) 379 137 2.4’ 747
16. (75/5‘) 163 263 7.6 5 mm
Delay. Surg.4*
1. (65/) 76 53 0.9 40305* 10 mm 4
2. (72/) 84 35 0.6 41365* 3 mm 50
3. (54/5‘) 197 57 1.9 19295* 6 mm
4. (26/) 75 142 1.5 12495* 3 mm 14
5. (62/5‘)6* 177 192 3.0 mm 4
6. (73/5‘)6* 89 145 2.6 57 10 mm 5
7. (36/5‘)6* 173 397 7.7 38 13 mm
8. (36/5‘)6* 153 355 7.3 89 16 mm
9. (44/) 165 140 1.2 111 2 mm 356
10. (50/9) 164 144 1.0 300 4 mm 137
11. (63/9) 579 605 3.6 4 mm 82
12. (63/9) 252 417 1.1 37 6 mm 44
13. (75/5‘) 292 284 3.0 mm 30
14. (52/5‘) 173 345 13.1 427 3 mm 18
15. (84/5‘) 157 74 3.3 3 mm 6
16. (84/9) 79 101 1.4 482 4 mm 4
17. (52/9) 104 174 1.0 352 15 mm 4
18. (81/) 80 46 1.1 33 8 mm 2
* GOT; serum glutamic oxalacetic transaminase (Karmen unit, N < 40), GPT; serum glutamic pyruvic
transaminase(Karmen unit,N < 35), T. bil; total bilirubin (mg/dl,N < 1.2), Amylase(Caraway unit,N < 135)
2* Minimum size of gallbladder stones
3* Emergency surgery
4* Delayed surgery
5* Biliary pancreatitis (Amylase activity > 1,000)
6* Patients undergoing laparoscopic cholecystectomy after endoscopic sphincterotomy (ES)272 M. ISOGAI et al.
papilloplasty or choledochoduodenostomy (drainage
procedure) in 34 (24.7%). At delayed surgery (58
patients), cholecystectomy, ductal exploration, and
drainage procedure were performed in seven (12.1%),
33 (56.9%), and 13 patients (22.4%), respectively. The
remaining five (8.6%) underwent laparoscopic chole-
cystectomy, among whom four underwent laparo-
scopic cholecystectomy after ES.
Outcome
Two patients in Group I died; the mortality rate was
thus 1.0% (2/197). These two patients were a 66-year-
old male and a 79-year-old male who both had SBDS
and underwent ductal exploration. The former died of
ruptured hepatic artery aneurysm, and the latter of
aspiration pneumonia, 13 days and 12 days, respective-
ly, after the initial biliary surgery. The postoperative
courses in the remaining 195 patients were generally
uneventful. There were no deaths associated with
severe acute cholangitis.
DISCUSSION
Several attempts have been made to define the clinical
and laboratory criteria that would identify high-risk
groups of patients with choledocholithiasis6-,
SBDS xx, or acute cholangitis2’2. Liver function tests
have been reported to be useful for identifying patients
with choledocholithiasis7’9, SBDS, and acute
cholangitis2. Few studies, however, have specifically
explained the reasons why liver function tests were
useful. In the study by Saharia et al.,
2 elevated serum
transaminase levels were considered to be a reflection
of the pathological condition of the bile duct2.
We have adopted the clinical concepts of gallstone
hepatitis as clinical and laboratory criteria for
identifying high-risk patients with acute cholangitis
or SBDS. The reasons were: (1) gallstone hepatitis
might be a sign of early biliary obstruction caused
by impacted bile duct stones; and (2) SBDS might
result from biliary tract obstruction, and acute cholan-
gitis from biliary tract obstruction and subsequent
infection. As a result, 197 patients with acute gall-
stone disease and concomitant elevation of serum
transaminases (gallstone hepatitis) were suspected
of having acute cholangitis or SBDS. Among them,
158 (80.2%) underwent emergency treatment either
surgery (138 patients) or PTBD/ES (20 patients).
In the acute stage of the disease, the majority (142;
89.9%) of the 158 patients were confirmed to have
SBDS, and less than half(67; 42.4%) were confirmed to
have ASC.
The majority ofpatients who had no bile duct stones
identified at surgery had either biliary pancreatitis or
multiple small stones in the gallbladder. Biliary pancre-
atitis is thought to be caused by the migration of
a stone into or through the ampulla of Vater. Ac-
cordingly, a considerable proportion of those patients
may have either passed stones or small stones not
detected by operative cholangiograms8’4.
The majority of patients had also acute inflamma-
tion of the gallbladder. The intensity of the gallbladder
inflammation, however, was slight. Accordingly, acute
inflammation of the gallbladder in patients with gall-
stone hepatitis was considered to be secondary to
SBDS4.
Seven patients had severe acute cholangitis. Our
previous study demonstrated necrosis of liver cells and
cholangitis in liver biopsy specimens taken from pa-
tients with gallstone hepatitisa’4. It must be stressed
that elevation of serum transaminases in patients with
gallstone hepatitis is a reflection of liver cell necrosis
caused by impacted bile duct stones. Once the bile duct
is obstructed by impacted bile duct stones, it becomes
a closed system filled with bile, and pathological
changes in the bile duct such as bile statis, increased
pressure in the biliar tract or infection may affect the
liver cells which bound the bile canaliculus and might
cause hepatocellular necrosis3’. Thus, it is possible
that bacterial cholangiovenous reflux might occur
through damaged tight junctional complexes and also
directly through hepatocytes
15 if bile stasis and infec-
tion remain in the bile duct, leading to the development
of severe acute cholangitis as shown in the case pres-
ented. The operative mortality rate in the 196 patients
of whom 63 (32.4%) and seven (3.6%) had ASC and
severe acute cholangitis, respectively, was 1.0% (2/196).
This low mortality rate could be attributable to: (1)
early biochemical prediction of SBDS and acute
cholangitis by gallstone hepatitis; and (2) initial non-
operative management for the majority of patients
with severe acute cholangitis using PTBD/ES.
In conclusion, the results of our study show
that gallstone hepatitis correctly predicted SBDS
and acute cholangitis in 89.8% and 42.4% of attacks,
respectively. In patients with acute gallstone disease,
gallstone hepatitis indicates that SBDS and acute
cholangitis are probable, and facilitates rapid selection
ofpatients for urgent biliary tract exploration. Patients
with gallstone hepatitis could develop into severe acute
cholangitis and should be managed promptly and
properly.GALLSTONE HEPATITIS AND ACUTE CHOLANGITIS 273
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